Parkinson’s disease(PD)is a common neurodegenerative disorder with increasing incidence and disability rates globally,placing a heavy burden on patients and their families.In the prodromal phase of PD,nonmotor sympto...
supported in part by the Intramural Research Program of the National Institute on Aging(NIA),the Center for Alzheimer’s and Related Dementias(CARD),within the Intramural Research Program of the National Institute on Aging and the National Institute of Neurological Disorders and Stroke(AG000546).
Parkinson’s disease(PD)diagnosis is based solely on clinical presentation[1].Therefore,diagnostic and prog-nostic biomarkers are needed.In recent years,seeding aggregation assays(SAA)have demonstrated the ability to ...
the National Natural Science Foundation of China(82171198,U20A20354);the Sci-Tech Innovation 2030 Agenda of China(2022ZD0211603).
Alzheimer's disease(AD)is a common cause of dementia,characterised by cerebral amyloid-βdeposition,pathological tau and neurodegeneration.The prodromal stage of AD(pAD)refers to patients with mild cognitive impairmen...
supported by the“Development of Korean Medicine Original Technology for Preventive Treatment based on Integrative Big Data”grant from the Korea Institute of Oriental Medicine(No.KSN2023120).
Metabolic syndrome(MetS)is a complex condition that significantly increases the risk of several diseases,including heart disease and diabetes.Patients with MetS show both pro-inflammatory and pro-thrombotic states;how...
There was no specific funding for this article.P.M.:reports lecture fees from Boston Scientific outside the submitted work and a grant from the Tiroler Wissenschaftsförderung(Grant UNI-0404/2245);K.M.:has been supported by a grant from the Tiroler Wissenschaftsförderung(Grant UNI-0404/2245);M.W.:Nothing to report.W.P.:reports personal fees from Alterity,AbbVie,Affiris,AstraZeneca,BIAL,Biogen,Britannia,Lilly,Lundbeck,Neuroderm,Neurocrine,Denali Pharmaceuticals,Novartis,Orion Pharma,Roche,Takeda,Teva,UCB,and Zambon(consultancy and lecture fees in relation to clinical drug development programs for PD);royalties from Thieme,Wiley Blackwell,Oxford University Press,and Cambridge University Press;and grant support from MJFF;EU FP7,and Horizon 2020 outside the submitted work.K.S.:reports personal fees from Teva,UCB,Lundbeck,AOP Orphan Pharmaceuticals AG,Roche,Grünenthal,Stada,Licher Pharma,Biogen,and Abbvie;honoraria from the International Parkinson and Movement Disorders Society;and research grants from FWF Austrian Science Fund,Michael J.Fox Foundation,and AOP Orphan Pharmaceuticals AG,outside the submitted work.
The ultimate goal in Parkinson’s disease (PD) research remains the identification of treatments that are capable of slowing or even halting the progression of the disease. The failure of numerous past disease-modific...
This research was supported by the National Natural Science Foundation of China(81870820 and 31671062 to N.-J.X.,81671047 to S.S.);Grants of Shanghai Brain-Intelligence Project from STCSM(16JC1420500);the Science and Technology Commission of Shanghai Municipality(18JC1420302);Innovation Program of Shanghai Municipal Education Commission(2017-01-07-00-01-E00046).
Background Neuropsychiatric symptoms(NPS)such as depression,anxiety,apathy,and irritability occur in prodromal phases of clinical Alzheimer’s disease(AD),which might be an increased risk for later developing AD.Here ...
Objective Non-motor symptoms are important prodromal characteristics of Parkinson's disease(PD).The siblings and the spouses of PD patients do not have classic motor symptoms.This study aimed to investigate if they ha...
Scientific Research Foundation of China supported this work(No.53631305);Xuzhou city(social development)project(No.KC15SM048);NSFC(81471330,81560168,81470684)and the Qing Lan Project.
Background:Parkinson’s disease(PD)is a neurodegenerative disease characterized by intraneuronal Lewy Body(LB)aggregates composed of misfolded alpha-synuclein(α-syn).The spread of misfoldedα-syn follows a typical pa...
Neurodegeneration of Parkinson’s disease(PD)starts in an insidious manner,30–50%of dopaminergic neurons have been lost in the substantia nigra before clinical diagnosis.Prodromal stage of the disease,during which th...
Department of Clinical Genetics, Karolinska University Hospital
This study investigated episodic memory in prodromal HD. Three groups were compared (N = 70): mutation carriers with less than 12.5 years to disease onset (n = 16), mutation carriers with 12.5 or more years to disease...